Loading...
Loading...
India's apixaban imports from SOUTH AFRICA total $423 across 5 shipments from 2 foreign suppliers. CIPLA MEDPRO DISTRIBUTION CENTRE leads with $294 in import value; the top 5 suppliers together control 100.0% of this origin. Leading Indian buyers include CIPLA LIMITED. This corridor reflects India's pharmaceutical import demand for apixaban โ a concentrated sourcing relationship with select suppliers from SOUTH AFRICA.

CIPLA MEDPRO DISTRIBUTION CENTRE is the leading Apixaban supplier from SOUTH AFRICA to India, with import value of $294 across 4 shipments. The top 5 suppliers โ CIPLA MEDPRO DISTRIBUTION CENTRE, DR REDDY'S LABORATORIES PTY LTD (S.A.) โ collectively account for 100.0% of total import value from this origin.
Ranked by import value (USD) ยท Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | CIPLA MEDPRO DISTRIBUTION CENTRE | $294 | 4 | 69.6% |
| 2 |
| DR REDDY'S LABORATORIES PTY LTD (S.A.) |
| $129 |
| 1 |
| 30.4% |
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | CIPLA LIMITED | $294 | 4 | 69.6% |
| 2 | DR.REDDY'S LABORATORIES LTD | $129 | 1 | 30.4% |
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
The top Apixaban suppliers from SOUTH AFRICA to India include CIPLA MEDPRO DISTRIBUTION CENTRE, DR REDDY'S LABORATORIES PTY LTD (S.A.). The leading supplier is CIPLA MEDPRO DISTRIBUTION CENTRE with import value of $294 USD across 4 shipments. India imported Apixaban worth $423 USD from SOUTH AFRICA in total across 5 shipments.
India imported Apixaban worth $423 USD from SOUTH AFRICA across 5 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
The main Indian buyers of Apixaban sourced from SOUTH AFRICA include CIPLA LIMITED, DR.REDDY'S LABORATORIES LTD. The largest buyer is CIPLA LIMITED with $294 in imports across 4 shipments.
The total value of Apixaban imports from SOUTH AFRICA to India is $423 USD, across 5 shipments and 2 foreign suppliers. Data source: Indian Customs (DGFT).
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records โ the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
5 Verified Shipments
2 suppliers, 2 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists